Voyageur Pharmaceuticals Ltd.
VM.V
TSX
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -86.11% | -264.44% | 6.20% | -133.37% | -61.17% |
| Total Depreciation and Amortization | -33.33% | -33.33% | -33.33% | -33.33% | -25.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -546.51% | 228.38% | 12.48% | 200.74% | -123.76% |
| Change in Net Operating Assets | 19.03% | -43.12% | -101.39% | -4,820.98% | 98.28% |
| Cash from Operations | -1,283.04% | -2,351.40% | -33.48% | -606.90% | -33.33% |
| Capital Expenditure | -156.42% | -108.71% | 47.86% | -6.09% | -5.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -156.42% | -108.71% | 47.86% | -6.09% | -5.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 29,039.29% | -- | 226.34% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -235.87% | -- | -1,830.56% | 1,222.13% | -- |
| Cash from Financing | -226.36% | 27,692.68% | 319.40% | 279.80% | 1,419.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -510.08% | 5,663.51% | -6.74% | 79.49% | 118,000.00% |